Stay updated on IRX-2 Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.

Latest updates to the IRX-2 Combo in Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting a minor publication/version update without altering the study information presented.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 deployed; appears to be a minor update with no changes to study content or eligibility criteria.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior v3.4.1 revision banner.SummaryDifference0.4%

- Check94 days agoChange DetectedThe page now includes notices about government funding and NIH operating status updates, and the site version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to IRX-2 Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.